334 related articles for article (PubMed ID: 22305131)
1. Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate.
Gardner CL; Burke CW; Higgs ST; Klimstra WB; Ryman KD
Virology; 2012 Apr; 425(2):103-12. PubMed ID: 22305131
[TBL] [Abstract][Full Text] [Related]
2. Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation.
Cook LE; Locke MC; Young AR; Monte K; Hedberg ML; Shimak RM; Sheehan KCF; Veis DJ; Diamond MS; Lenschow DJ
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619554
[TBL] [Abstract][Full Text] [Related]
3. Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling.
Partidos CD; Weger J; Brewoo J; Seymour R; Borland EM; Ledermann JP; Powers AM; Weaver SC; Stinchcomb DT; Osorio JE
Vaccine; 2011 Apr; 29(16):3067-73. PubMed ID: 21300099
[TBL] [Abstract][Full Text] [Related]
4. Liposomal Delivery of the RNA Genome of a Live-Attenuated Chikungunya Virus Vaccine Candidate Provides Local, but Not Systemic Protection After One Dose.
Abeyratne E; Tharmarajah K; Freitas JR; Mostafavi H; Mahalingam S; Zaid A; Zaman M; Taylor A
Front Immunol; 2020; 11():304. PubMed ID: 32194557
[TBL] [Abstract][Full Text] [Related]
5. A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.
García-Arriaza J; Cepeda V; Hallengärd D; Sorzano CÓ; Kümmerer BM; Liljeström P; Esteban M
J Virol; 2014 Mar; 88(6):3527-47. PubMed ID: 24403588
[TBL] [Abstract][Full Text] [Related]
6. Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice.
Hallengärd D; Kakoulidou M; Lulla A; Kümmerer BM; Johansson DX; Mutso M; Lulla V; Fazakerley JK; Roques P; Le Grand R; Merits A; Liljeström P
J Virol; 2014 Mar; 88(5):2858-66. PubMed ID: 24371047
[TBL] [Abstract][Full Text] [Related]
7. DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice.
Tretyakova I; Hearn J; Wang E; Weaver S; Pushko P
J Infect Dis; 2014 Jun; 209(12):1882-90. PubMed ID: 24585894
[TBL] [Abstract][Full Text] [Related]
8. Gene profiling of Chikungunya virus arthritis in a mouse model reveals significant overlap with rheumatoid arthritis.
Nakaya HI; Gardner J; Poo YS; Major L; Pulendran B; Suhrbier A
Arthritis Rheum; 2012 Nov; 64(11):3553-63. PubMed ID: 22833339
[TBL] [Abstract][Full Text] [Related]
9. Interferon Alpha, but Not Interferon Beta, Acts Early To Control Chronic Chikungunya Virus Pathogenesis.
Locke MC; Fox LE; Dunlap BF; Young AR; Monte K; Lenschow DJ
J Virol; 2022 Jan; 96(1):e0114321. PubMed ID: 34668781
[TBL] [Abstract][Full Text] [Related]
10. Chikungunya virus host range E2 transmembrane deletion mutants induce protective immunity against challenge in C57BL/6J mice.
Piper A; Ribeiro M; Smith KM; Briggs CM; Huitt E; Nanda K; Spears CJ; Quiles M; Cullen J; Thomas ME; Brown DT; Hernandez R
J Virol; 2013 Jun; 87(12):6748-57. PubMed ID: 23552427
[TBL] [Abstract][Full Text] [Related]
11. Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock.
Rudd PA; Wilson J; Gardner J; Larcher T; Babarit C; Le TT; Anraku I; Kumagai Y; Loo YM; Gale M; Akira S; Khromykh AA; Suhrbier A
J Virol; 2012 Sep; 86(18):9888-98. PubMed ID: 22761364
[TBL] [Abstract][Full Text] [Related]
12. Infectious Chikungunya Virus (CHIKV) with a Complete Capsid Deletion: a New Approach for a CHIKV Vaccine.
Zhang YN; Deng CL; Li JQ; Li N; Zhang QY; Ye HQ; Yuan ZM; Zhang B
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092567
[TBL] [Abstract][Full Text] [Related]
13. Lower temperatures reduce type I interferon activity and promote alphaviral arthritis.
Prow NA; Tang B; Gardner J; Le TT; Taylor A; Poo YS; Nakayama E; Hirata TDC; Nakaya HI; Slonchak A; Mukhopadhyay P; Mahalingam S; Schroder WA; Klimstra W; Suhrbier A
PLoS Pathog; 2017 Dec; 13(12):e1006788. PubMed ID: 29281739
[TBL] [Abstract][Full Text] [Related]
14. Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model.
Chu H; Das SC; Fuchs JF; Suresh M; Weaver SC; Stinchcomb DT; Partidos CD; Osorio JE
Vaccine; 2013 Jul; 31(33):3353-60. PubMed ID: 23727003
[TBL] [Abstract][Full Text] [Related]
15. Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes.
Pal P; Fox JM; Hawman DW; Huang YJ; Messaoudi I; Kreklywich C; Denton M; Legasse AW; Smith PP; Johnson S; Axthelm MK; Vanlandingham DL; Streblow DN; Higgs S; Morrison TE; Diamond MS
J Virol; 2014 Aug; 88(15):8213-26. PubMed ID: 24829346
[TBL] [Abstract][Full Text] [Related]
16. Chimeric alphavirus vaccine candidates for chikungunya.
Wang E; Volkova E; Adams AP; Forrester N; Xiao SY; Frolov I; Weaver SC
Vaccine; 2008 Sep; 26(39):5030-9. PubMed ID: 18692107
[TBL] [Abstract][Full Text] [Related]
17. A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice.
Teo TH; Lum FM; Claser C; Lulla V; Lulla A; Merits A; Rénia L; Ng LF
J Immunol; 2013 Jan; 190(1):259-69. PubMed ID: 23209328
[TBL] [Abstract][Full Text] [Related]
18. Chikungunya Virus Exposure Partially Cross-Protects against Mayaro Virus Infection in Mice.
Fumagalli MJ; de Souza WM; de Castro-Jorge LA; de Carvalho RVH; Castro ÍA; de Almeida LGN; Consonni SR; Zamboni DS; Figueiredo LTM
J Virol; 2021 Nov; 95(23):e0112221. PubMed ID: 34549980
[TBL] [Abstract][Full Text] [Related]
19. Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice.
Ashbrook AW; Burrack KS; Silva LA; Montgomery SA; Heise MT; Morrison TE; Dermody TS
J Virol; 2014 Nov; 88(21):12180-92. PubMed ID: 25142598
[TBL] [Abstract][Full Text] [Related]
20. Extended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine Candidate.
Plante KS; Rossi SL; Bergren NA; Seymour RL; Weaver SC
PLoS Negl Trop Dis; 2015; 9(9):e0004007. PubMed ID: 26340754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
